Peter Pitts doesn’t like the KSR decision, or prizesP
Peter Pitts doesn’t like the KSR decision, and he also doesn’t like prizes. His recent Spectator article says:
DISTURBINGLY, SOME FOLKS ARE now advocating a “prize” system where there are no drug patents. Instead, the government would pay a drug maker a lump sum for its innovation, and then the new drug would immediately be placed in the public domain.